Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about gene editing

Recent news which mentions gene editing

Biotech ETF SBIO Sees Buy Signal Amid Hot Returns
Tickers ACAD ALPS SBIO ZLAB
Tags biotech etf gene editing ZLAB
From ETF Trends
Play US Gene Treatment Approval in SBIO
Tickers ALPS SBIO
Tags ALPS CRISPR SBIO
From ETF Trends
Bill Gates Gets Excited About Future Of Tech That Has 'Revolutionized Health' Over Past Decade
Tickers TECH
Tags Benzinga Joy Wang Market News
From Benzinga
Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection
Tickers BEAM
Tags News Preclinical Phase Biotech
From Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Tickers BLUE NTLA
Tags Penny Stocks Health Care FDA
From Benzinga
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
Tickers EDIT
Tags Briefs General Gene Editing
From Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
Tickers NTLA REGN
Tags Health Care Benzinga Trading Ideas
From Benzinga
Sarepta Bets On GenEdit's Nanoparticles' In $57M Gene Editing Partnership
Tickers SRPT
Tags Biotech News Gene Editing
From Benzinga
Pfizer, Beam Ink Multi-Target Research Collaboration For In Vivo Base Editing Programs
Tickers BEAM PFE
Tags why it's moving Biotech Trading Ideas
From Benzinga
Jennifer Doudna Spinout Mammoth Inks $700M CRISPR Deal With Vertex
Tickers VRTX
Tags Biotech Health Care VRTX
From Benzinga
Sana Obtains License To Beam Therapeutics' CRISPR Cas12b Gene Editing Technology
Tickers BEAM SANA
Tags Briefs General Market News
From Benzinga
Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients
Tickers NTLA
Tags News Phase 1 Trial Market News
From Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
Tickers EDIT
Tags EDIT News Phase 1 Trial
From Benzinga
Wave Life Sciences Shows Durable ADAR-Editing In Multiple Tissues In Animal Studies
Tickers WVE
Tags General Briefs Health Care
From Benzinga
Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection
Tickers BEAM
Tags Biotech Preclinical Phase News
From Benzinga
Beam Therapeutics' Formulated LNP Show Tolerance, Early Storage Stability In Animal Studies
Tickers BEAM
Tags News Preclinical Phase Biotech
From Benzinga
How Colossal sold investors on a quest to resurrect a woolly mammoth
Tickers TC
Tags Science CRISPR mammoth
From TechCrunch
Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn
Tickers TC
Tags biotech therapeutics CRISPR
From TechCrunch
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
Tickers RHHBF RHHBY RHHVF
Tags News Market News Gene Editing
From Benzinga
Vertex Inks Potential $1.2B Gene-Editing Pact With Arbor Biotechnologies
Tickers VRTX
Tags Biotech Sickle Cell Disease Benzinga
From Benzinga
Editas Medicine Unveils Preclinical Data From New Gene Editing Technology
Tickers EDIT
Tags Biotech Health Care Long Ideas
From Benzinga
New Technologies Driving the Future of Plant Breeding
Tags Bayer Plant Breeding FWB:BAYN
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish
Tickers GENE GRPH
Tags Initiation Analyst Color GRPH
From Benzinga
Heart Disease Company Tenaya Therapeutics Files For $100M US IPO
Tickers FPX IPO IPOS
Tags Offerings News FPX
From Benzinga
WHO Issues Framework For Governance For Gene Editing Technologies
Tickers BEAM CRSP EDIT NTLA
Tags Benzinga BEAM Health Care
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.